LEONHARDT VENTURES NEWS
Leonhardt Ventures and Lionheart Health Announce Patent Application Filing for Bioelectric Control of SESTRINs Anti-Aging Protein Expressions
Strengthens deep pipeline of longevity and wellness intellectual property Leonhardt Ventures LLC, and its commercial distribution arm Lionheart Health, Inc., has filed a series of patent claims for bioelectric controlled expression of the SESTRINs family of anti-aging...
TremorStim Unveils 2nd Generation Combination Head and Wrist Band Bioelectric Device for Treatment of Essential Tremor
Irvine, California (Newsworthy.ai) Wednesday Nov 23, 2022 @ 4:00 AM Central — TremorStim, a Leonhardt Ventures LLC startup, unveiled today its 2nd generation combination bioelectric stimulation device for treating essential tremor comprised of an easily applied,...
U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures
Mission Viejo, California, United States, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures, LLC is pleased to announce the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,471,686 covering bioelectric stimulation control of...
Howard Leonhardt Finalist for Best Technology CEO of the Year Award Orange County hosted by Octane
Irvine, CA - October 1, 2022 - Howard Leonhardt CEO of Leonhardt Ventures LLC and Leonhardt's Launchpads was a FINALIST for Best Technology CEO of the Year Award hosted by Octane https://octaneoc.org/hta-finalists-winners/. The High Tech Awards Ceremony was held...
Leonhardt Ventures LLC Patent Licenses 2022
Leonhardt Ventures LLC Patent Licenses https://patents.justia.com/inventor/howard-j-leonhardt www.lventuresnestg.wpenginepowered.com Licenses are for all patents issued and filed during period that these startups/innovation platforms were in our accelerator program,...
Mid-Year 2022 Semi-Annual Report
Focused on the Convergence of Bioelectrics and Biologics for Organ Regeneration and Healing An extensive pipeline of 35+ innovations in five areas: Heart and Cardiovascular Brain Cosmetic and Personal Care Major Organ Regeneration Cancer Learn More We employ our...
Leonhardt Ventures Announces Filing of Pioneering Patent Application for Bioelectric Protein Expression Control of the SIRT
SIRT signaling proteins (1-7) are involved in metabolic regulation, inflammation, neurodegeneration, cell cycle/tumorigenesis, Insulin secretion, DNA repair, and rDNA transcription and play a key role during cell response to a variety of stresses, such as oxidative or...
Executive Chairman’s Best guess estimate June 2022 on portfolio assets closest to exit
Note - ALL bioelectric products are based on same exact core stimulator with only slightly different signal sequence protocols. Nearly all use our stem cell homing and circulation improving signals common. So in sense we have only two highly focused startups...
May 9, 2022 Update Leonhardt Ventures LLC and Leonhardt’s Launchpads
Update Leonhardt Ventures LLC May 2022